Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Intellia Thera CS (NTLA)

Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
2 Stocks Down 30% to Buy Right Now

These stocks have plenty of catalysts ahead.

NTLA : 20.65 (+3.15%)
MRNA : 107.32 (+1.07%)
Cathie Wood Goes Bargain Hunting. 2 Stocks She Bought This Week.

These two stocks could be ripe for a rebound.

TDOC : 13.16 (-1.28%)
NTLA : 20.65 (+3.15%)
Bull Market and Beyond: 3 Stocks Just Waiting to Soar

These stocks, a bargain today, are players to hold on to for the long term.

CRSP : 54.19 (+0.86%)
LLY : 736.13 (+1.55%)
PFE : 25.53 (+1.07%)
MRNA : 107.32 (+1.07%)
NTLA : 20.65 (+3.15%)
DNA : 0.8415 (+8.20%)
Better Cathie Wood Stock: Moderna vs. Intellia

Moderna and Intellia have declined in the double digits over the past year.

MRNA : 107.32 (+1.07%)
NTLA : 20.65 (+3.15%)
Is Intellia Therapeutics Stock a Buy Now?

The company's future will depend on its innovative qualities.

NTLA : 20.65 (+3.15%)
Intellia Therapeutics Stock Has 119% Upside, According to 1 Wall Street Analyst

2024 could see the start of its first late-stage clinical trials.

NTLA : 20.65 (+3.15%)
A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now

The futures for these two beaten-down stocks could be brighter than their recent pasts.

CRSP : 54.19 (+0.86%)
MRK : 131.26 (+0.41%)
NTLA : 20.65 (+3.15%)
MRNA : 107.32 (+1.07%)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The popular money manager added to these three existing positions on Monday following disappointing financial updates earlier this month.

ROKU : 57.35 (-8.69%)
TXG : 27.60 (+2.60%)
NTLA : 20.65 (+3.15%)
Cathie Wood Is Betting on This Top Technology: 2 Stocks She Just Bought

These exciting players could deliver explosive growth over time.

VRTX : 399.27 (+0.39%)
ARKK : 44.03 (+0.96%)
ARKG : 23.15 (+0.61%)
CRSP : 54.19 (+0.86%)
NTLA : 20.65 (+3.15%)
Analysts Say Intellia Therapeutics Stock Could Rise 157% This Year, but Will It Happen?

Good news may be on the way, but it will be a while before it arrives.

NTLA : 20.65 (+3.15%)

Barchart Exclusives

Microsoft Shows Massive FCF Growth Despite High AI Spending - MSFT Looks Undervalued
Microsoft produced excellent quarterly results with higher free cash flow despite increased AI capex spending. This makes MSFT look undervalued here and provides a good opportunity for short-put investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar